You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gynecologic, 
Cervix
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025

Pages